BeOne Medicines
ONC
#675
Rank
C$47.62 B
Marketcap
C$430.39
Share price
1.64%
Change (1 day)
69.23%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Sustainability Reports

Thumbnail BeOne Medicines Sustainability Report 2023

Sustainability Report 2023

Language: English

View Sustainability Report
Thumbnail BeOne Medicines Sustainability Report 2020

Sustainability Report 2020

Language: English

View Sustainability Report